Johnson Matthey PLC (LON:JMAT - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 1,417.35 ($19.45) and traded as high as GBX 1,717 ($23.56). Johnson Matthey shares last traded at GBX 1,708 ($23.43), with a volume of 348,658 shares changing hands.
Johnson Matthey Price Performance
The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45. The business's 50 day simple moving average is GBX 1,532.19 and its 200-day simple moving average is GBX 1,422.84. The stock has a market capitalization of £2.95 billion, a price-to-earnings ratio of 29.94, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey (LON:JMAT - Get Free Report) last posted its earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.05) earnings per share (EPS) for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. Research analysts anticipate that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.
Johnson Matthey Increases Dividend
The company also recently announced a dividend, which was paid on Wednesday, April 16th. Shareholders of record on Thursday, April 10th were paid a dividend of GBX 32 ($0.44) per share. This represents a yield of 1.88%. This is a positive change from Johnson Matthey's previous dividend of $22.00. The ex-dividend date was Thursday, April 10th. Johnson Matthey's payout ratio is presently 130.84%.
Insider Buying and Selling at Johnson Matthey
In related news, insider Liam Condon purchased 30 shares of Johnson Matthey stock in a transaction dated Wednesday, April 16th. The stock was bought at an average cost of GBX 1,200 ($16.46) per share, with a total value of £360 ($493.89). Insiders bought 62 shares of company stock valued at $84,978 in the last ninety days. Company insiders own 0.61% of the company's stock.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Further Reading
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
